Screener
McKesson MCK Prescription Technology Solutions — Other adjustments
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by McKesson in its filing.
Tagged under the XBRL concept us-gaap:GoodwillPurchaseAccountingAdjustments.
The source filing: McKesson’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 5:29 PM EDT
- Fiscal quarter
- Q1 FY2027
- Calendar quarter
- Q2 2026
- Accession
- 0000927653-26-000234
| (In millions) | North American Pharmaceutical | Oncology & Multispecialty | Prescription Technology Solutions | Medical-Surgical Solutions | Total |
|---|---|---|---|---|---|
| Balance, March 31, 2026 | $2,781 | $3,963 | $2,065 | $2,507 | $11,316 |
| Goodwill acquired | — | 13 | — | — | 13 |
| Disposals | — | (2) | — | — | (2) |
| Foreign currency translation adjustments, net | (26) | — | — | — | (26) |
| Other adjustments (1) | — | (23) | — | — | (23) |
| Balance, June 30, 2026 | $2,755 | $3,951 | $2,065 | $2,507 | $11,278 |
Item 1. Condensed Consolidated Financial Statements.
FAQ
- What is McKesson's prescription technology solutions — other adjustments?
- McKesson (MCK) reported prescription technology solutions — other adjustments of $0 in Q2 2026.
- What does prescription technology solutions — other adjustments mean?
- This metric aggregates miscellaneous non-recurring or non-operational items specific to the Prescription Technology Solutions segment. It includes adjustments that do not fit into standard categories like depreciation or amortization. Investors use this to normalize segment performance by excluding one-time events.
Ask your AI about McKesson's prescription technology solutions — other adjustments.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude